Free Trial

UGI (UGI) Financials

UGI logo
$33.83 +0.58 (+1.74%)
As of 10:07 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Annual Income Statements for UGI

Annual Income Statements for UGI

This table shows UGI's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 9/30/2015 9/30/2016 9/30/2017 9/30/2018 9/30/2019 9/30/2020 9/30/2021 9/30/2022 9/30/2023 9/30/2024 9/30/2025
Net Income / (Loss) Attributable to Common Shareholders
281 365 437 719 256 532 1,467 1,073 -1,502 269 678
Consolidated Net Income / (Loss)
414 489 524 822 308 532 1,467 1,074 -1,502 269 678
Net Income / (Loss) Continuing Operations
414 489 524 822 308 532 1,467 1,074 -1,502 269 678
Total Pre-Tax Income
592 710 701 855 401 667 1,989 1,387 -1,837 340 696
Total Operating Income
835 988 1,010 1,065 617 982 2,350 1,666 -1,444 770 1,107
Total Gross Profit
2,955 3,248 3,283 3,576 2,997 3,410 4,833 4,133 1,991 3,681 3,633
Total Revenue
6,691 5,686 6,121 7,651 7,320 6,559 7,447 10,106 8,928 7,210 7,287
Operating Revenue
6,691 5,686 6,121 7,651 7,320 6,559 7,447 10,106 8,928 7,210 7,287
Total Cost of Revenue
3,737 2,438 2,837 4,075 4,323 3,149 2,614 5,973 6,937 3,529 3,654
Operating Cost of Revenue
3,737 2,438 2,837 4,075 4,323 3,149 2,614 5,973 6,937 3,529 3,654
Total Operating Expenses
2,120 2,260 2,273 2,511 2,380 2,428 2,483 2,467 3,214 2,816 2,490
Selling, General & Admin Expense
1,774 1,882 1,868 2,013 1,963 1,911 2,014 2,028 2,158 2,132 2,011
Depreciation Expense
313 401 416 455 448 484 502 518 532 551 561
Other Operating Expenses / (Income)
-28 -22 -11 -32 -31 -21 -33 -79 -132 -62 -82
Impairment Charge
- 0.00 0.00 75 - - 0.00 0.00 656 195 0.00
Total Other Income / (Expense), net
-243 -278 -309 -210 -216 -315 -361 -279 -614 -525 -447
Interest Expense
242 278 283 230 264 322 310 340 388 403 421
Interest & Investment Income
-1.20 -0.20 4.30 4.00 9.00 27 -63 -14 2.00 -19 5.00
Other Income / (Expense), net
0.00 0.00 -30 16 39 -20 12 75 -228 -103 -31
Income Tax Expense
178 221 178 33 93 135 522 313 -335 71 18
Basic Earnings per Share
$1.62 $2.11 $2.51 $4.13 $1.44 $2.55 $7.02 $5.11 ($7.16) $1.27 $3.15
Weighted Average Basic Shares Outstanding
173.12M 173.15M 173.66M 173.91M 178.42M 208.93M 209.06M 209.94M 209.81M 211.31M 214.95M
Diluted Earnings per Share
$1.60 $2.08 $2.46 $4.06 $1.41 $2.54 $6.92 $4.97 ($7.16) $1.25 $3.09
Weighted Average Diluted Shares Outstanding
175.67M 175.57M 177.16M 176.91M 181.11M 209.87M 212.13M 215.82M 209.81M 215.27M 219.16M
Weighted Average Basic & Diluted Shares Outstanding
173.50M 172.80M 173.90M 174M 209.01M 208.42M 209.22M 209.69M 210.90M 214.70M 214.53M
Cash Dividends to Common per Share
$0.89 $0.93 $0.98 $1.02 $1.15 $1.31 $1.35 $1.41 $1.47 $1.50 $1.50

Quarterly Income Statements for UGI

This table shows UGI's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
131 94 496 -48 -273 375 479 -163 -13 297 520
Consolidated Net Income / (Loss)
131 94 496 -48 -273 375 479 -163 -13 297 520
Net Income / (Loss) Continuing Operations
131 94 496 -48 -273 375 479 -163 -13 297 520
Total Pre-Tax Income
157 120 629 -55 -354 417 594 -228 -87 351 660
Total Operating Income
237 232 717 67 -246 487 700 -93 13 454 758
Total Gross Profit
825 919 1,437 741 584 1,107 1,365 557 604 1,071 1,498
Total Revenue
1,404 2,121 2,467 1,380 1,242 2,030 2,666 1,394 1,197 2,083 2,685
Operating Revenue
1,404 2,121 2,467 1,380 1,242 2,030 2,666 1,394 1,197 2,083 2,685
Total Cost of Revenue
579 1,202 1,030 639 658 923 1,301 837 593 1,012 1,187
Operating Cost of Revenue
579 1,202 1,030 639 658 923 1,301 837 593 1,012 1,187
Total Operating Expenses
588 659 720 611 831 620 665 596 609 617 740
Selling, General & Admin Expense
519 530 591 501 510 497 546 481 487 520 559
Depreciation Expense
135 137 138 139 137 138 138 140 145 140 138
Other Operating Expenses / (Income)
-66 -8.00 -9.00 -29 51 -15 -19 -25 -23 -43 43
Total Other Income / (Expense), net
-80 -140 -88 -185 -107 -70 -106 -189 -82 -103 -98
Interest Expense
98 100 100 103 100 102 102 111 106 111 111
Interest & Investment Income
- 1.00 1.00 -24 3.00 3.00 3.00 0.00 -1.00 4.00 5.00
Other Income / (Expense), net
18 -41 11 -58 -10 29 -7.00 -78 25 4.00 8.00
Income Tax Expense
26 26 133 -7.00 -81 42 115 -65 -74 54 140
Basic Earnings per Share
$0.62 $0.45 $2.36 ($0.23) ($1.31) $1.74 $2.23 ($0.76) ($0.06) $1.38 $2.42
Weighted Average Basic Shares Outstanding
209.81M 209.78M 209.83M 210.68M 211.31M 214.93M 214.98M 214.81M 214.95M 214.84M 214.83M
Diluted Earnings per Share
$0.63 $0.44 $2.30 ($0.23) ($1.26) $1.74 $2.19 ($0.76) ($0.08) $1.34 $2.33
Weighted Average Diluted Shares Outstanding
209.81M 215.57M 215.25M 210.68M 215.27M 215.70M 218.94M 214.81M 219.16M 221.42M 222.71M
Weighted Average Basic & Diluted Shares Outstanding
210.90M 209.55M 209.62M 214.69M 214.70M 214.81M 214.44M 214.92M 214.53M 214.64M 214.39M
Cash Dividends to Common per Share
- $0.38 $0.38 $0.38 - $0.38 $0.38 $0.38 - $0.38 $0.38

Annual Cash Flow Statements for UGI

This table details how cash moves in and out of UGI's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 9/30/2015 9/30/2016 9/30/2017 9/30/2018 9/30/2019 9/30/2020 9/30/2021 9/30/2022 9/30/2023 9/30/2024 9/30/2025
Net Change in Cash & Equivalents
-50 133 30 -102 65 -154 520 -408 -129 -112 127
Net Cash From Operating Activities
1,164 970 964 1,085 1,078 1,102 1,481 716 1,107 1,182 1,227
Net Cash From Continuing Operating Activities
1,164 970 945 1,081 1,078 1,102 1,481 716 1,107 1,182 1,227
Net Income / (Loss) Continuing Operations
414 489 524 822 308 532 1,467 1,074 -1,502 269 678
Consolidated Net Income / (Loss)
414 489 524 822 308 532 1,467 1,074 -1,502 269 678
Depreciation Expense
374 401 416 455 448 484 502 518 532 551 561
Non-Cash Adjustments To Reconcile Net Income
51 51 -12 141 12 95 151 104 966 333 35
Changes in Operating Assets and Liabilities, net
325 29 37 -337 310 -9.00 -639 -980 1,111 29 -47
Net Cash From Investing Activities
-976 -559 -769 -749 -2,055 -649 -1,113 -1,012 -1,077 -792 -699
Net Cash From Continuing Investing Activities
-976 -559 -769 -749 -2,055 -649 -1,113 -1,012 -1,077 -792 -699
Purchase of Property, Plant & Equipment
-491 -564 -639 -574 -705 -655 -690 -804 -974 -796 -837
Acquisitions
-448 -61 -101 -187 -1,362 -16 -462 -289 -155 -92 -38
Purchase of Investments
- - - - - - - - 22 3.00 -4.00
Divestitures
- - - - - - 39 44 30 93 170
Other Investing Activities, net
-38 66 -29 12 12 22 0.00 11 0.00 0.00 10
Net Cash From Financing Activities
-217 -275 -147 -438 1,042 -635 166 -51 -168 -506 -406
Net Cash From Continuing Financing Activities
-217 -275 -147 -438 1,042 -635 166 -51 -168 -506 -406
Repayment of Debt
-465 -1,570 -1,066 -191 -749 -535 -440 -977 -1,764 -1,497 -1,753
Repurchase of Common Equity
-34 -48 -43 -60 -17 -38 0.00 -38 -22 0.00 -33
Payment of Dividends
-402 -418 -431 -440 -992 -273 -282 -296 -308 -318 -322
Issuance of Debt
672 1,747 1,382 218 2,783 209 656 1,257 1,930 1,321 1,684
Issuance of Common Equity
12 14 11 35 17 2.00 19 19 12 0.00 18
Other Financing Activities, net
- - 0.00 - - 0.00 0.00 -16 -16 -12 0.00
Effect of Exchange Rate Changes
-20 -2.90 - - - 28 -14 -61 9.00 4.00 5.00
Cash Interest Paid
227 229 202 222 248 311 297 320 332 403 375
Cash Income Taxes Paid
173 135 98 118 74 75 96 61 -17 80 55

Quarterly Cash Flow Statements for UGI

This table details how cash moves in and out of UGI's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
2.00 -38 6.00 -97 17 18 192 -68 -15 -84 259
Net Cash From Operating Activities
250 119 522 390 151 164 684 289 90 66 664
Net Cash From Continuing Operating Activities
250 119 522 390 151 164 684 289 90 66 664
Net Income / (Loss) Continuing Operations
131 94 496 -48 -273 375 479 -163 -13 297 520
Consolidated Net Income / (Loss)
131 94 496 -48 -273 375 479 -163 -13 297 520
Depreciation Expense
135 137 138 139 137 138 138 140 145 140 138
Non-Cash Adjustments To Reconcile Net Income
-31 32 20 78 203 12 9.00 64 -50 -22 46
Changes in Operating Assets and Liabilities, net
15 -138 -127 210 84 -361 58 248 8.00 -349 -40
Net Cash From Investing Activities
-316 -165 -188 -198 -241 -232 -135 -132 -200 -145 -152
Net Cash From Continuing Investing Activities
-316 -165 -188 -198 -241 -232 -135 -132 -200 -145 -152
Purchase of Property, Plant & Equipment
-304 -156 -169 -205 -266 -211 -146 -222 -258 -221 -170
Acquisitions
-45 -19 -28 -19 -26 -25 - -1.00 -12 -2.00 -2.00
Divestitures
33 - - - 51 4.00 - - 63 78 20
Net Cash From Financing Activities
76 3.00 -324 -287 102 95 -363 -237 99 -6.00 -247
Net Cash From Continuing Financing Activities
76 3.00 -324 -287 102 95 -363 -237 99 -6.00 -247
Repayment of Debt
95 -244 -321 -684 -248 -699 -291 -717 -46 -275 -213
Repurchase of Common Equity
12 -4.00 -4.00 -4.00 12 0.00 -17 - -16 -12 -11
Payment of Dividends
-78 -79 -78 -81 -80 -81 -80 -80 -81 -81 -80
Issuance of Debt
63 330 79 482 430 875 24 546 239 350 55
Issuance of Common Equity
- - - - - 0.00 - 14 3.00 12 2.00
Effect of Exchange Rate Changes
-8.00 5.00 -4.00 - - -9.00 6.00 - - 1.00 -6.00

Annual Balance Sheets for UGI

This table presents UGI's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 9/30/2015 9/30/2016 9/30/2017 9/30/2018 9/30/2019 9/30/2020 9/30/2021 9/30/2022 9/30/2023 9/30/2024 9/30/2025
Total Assets
10,514 10,847 11,582 11,981 13,347 13,985 16,723 17,575 15,401 15,098 15,462
Total Current Assets
1,460 1,424 1,698 1,888 1,566 1,543 3,270 3,802 2,045 1,651 1,766
Cash & Equivalents
370 503 558 453 447 336 855 405 241 213 335
Restricted Cash
69 16 10 9.60 64 21 22 64 99 15 20
Short-Term Investments
23 31 63 143 29 44 - - 75 29 23
Accounts Receivable
620 552 627 752 641 652 880 1,127 878 709 714
Inventories, net
240 210 279 318 230 241 469 665 433 411 385
Prepaid Expenses
114 97 84 130 72 96 135 110 123 113 204
Current Deferred & Refundable Income Taxes
7.80 - - - 0.00 80 128 128 36 56 41
Other Current Assets
16 16 76 83 83 73 781 1,008 160 105 35
Other Current Nonoperating Assets
- - - - - - 0.00 295 - - 9.00
Plant, Property, & Equipment, net
4,994 5,238 5,537 5,808 6,688 6,960 7,558 8,040 8,547 8,763 9,080
Total Noncurrent Assets
4,060 4,185 4,348 4,285 5,093 5,482 5,895 5,733 4,809 4,684 4,616
Goodwill
2,953 2,989 3,107 3,160 3,456 3,518 3,770 3,612 3,027 2,871 2,852
Intangible Assets
610 580 612 514 709 677 583 500 443 391 328
Other Noncurrent Operating Assets
497 616 629 611 928 1,287 1,542 1,621 1,339 1,422 1,436
Total Liabilities & Shareholders' Equity
10,514 10,847 11,582 11,981 13,347 13,985 16,723 17,575 15,401 15,098 15,462
Total Liabilities
6,942 7,252 7,841 7,881 9,520 9,848 11,192 11,501 11,007 10,744 10,676
Total Current Liabilities
1,679 1,442 1,690 1,732 2,028 1,755 2,297 2,444 2,274 2,060 1,981
Short-Term Debt
448 321 544 444 820 400 477 517 706 700 603
Accounts Payable
393 391 440 562 439 475 837 891 613 544 511
Other Current Liabilities
405 325 314 343 405 514 594 645 581 421 867
Other Current Nonoperating Liabilities
57 48 61 61 63 - 0.00 19 - - 0.00
Total Noncurrent Liabilities
5,263 5,810 6,151 6,149 7,492 8,093 8,895 9,057 8,733 8,684 8,695
Long-Term Debt
3,410 3,766 3,995 4,147 5,780 5,981 6,339 6,483 6,543 6,443 6,531
Noncurrent Deferred & Payable Income Tax Liabilities
1,138 1,216 1,357 992 541 640 1,137 1,305 928 1,008 973
Other Noncurrent Operating Liabilities
716 829 800 1,010 1,171 1,472 1,419 1,269 1,262 1,233 1,191
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
3,572 3,595 3,741 4,100 3,827 4,137 5,531 6,074 4,394 4,354 4,786
Total Preferred & Common Equity
2,692 2,844 3,163 3,681 3,817 4,128 5,522 6,066 4,386 4,345 4,777
Total Common Equity
2,692 2,844 3,163 3,681 3,817 4,128 5,309 5,904 4,219 4,345 4,777
Common Stock
1,215 1,202 1,189 1,201 1,397 1,416 1,394 1,483 1,503 1,676 1,709
Retained Earnings
1,637 1,834 2,107 2,611 2,653 2,908 4,081 4,841 3,027 2,978 3,334
Treasury Stock
-45 -37 -39 -20 -16 -49 -26 -40 -55 -56 -93
Accumulated Other Comprehensive Income / (Loss)
-115 -155 -93 -110 -217 -147 -140 -380 -256 -253 -173
Noncontrolling Interest
880 751 578 419 10 9.00 9.00 8.00 8.00 9.00 9.00

Quarterly Balance Sheets for UGI

This table presents UGI's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 12/31/2022 3/31/2023 6/30/2023 12/31/2023 3/31/2024 6/30/2024 12/31/2024 3/31/2025 6/30/2025 12/31/2025 3/31/2026
Total Assets
17,128 16,429 15,243 15,716 15,624 15,066 15,412 15,746 15,362 15,815 16,119
Total Current Assets
3,456 2,760 2,035 2,285 2,214 1,716 2,047 2,300 1,799 2,101 2,511
Cash & Equivalents
317 321 260 204 263 183 240 426 350 251 494
Restricted Cash
227 82 78 98 45 28 6.00 12 20 20 36
Short-Term Investments
238 110 31 41 38 39 52 47 8.00 14 58
Accounts Receivable
1,578 1,487 955 1,188 1,192 827 1,023 1,183 825 1,052 1,178
Inventories, net
618 433 410 441 375 379 381 341 359 392 319
Prepaid Expenses
331 233 272 193 167 186 142 149 154 164 216
Current Deferred & Refundable Income Taxes
- - - - 36 36 58 40 44 42 42
Other Current Assets
147 94 29 120 98 38 145 101 39 166 91
Other Current Nonoperating Assets
- - - - - - - 1.00 - - 77
Plant, Property, & Equipment, net
8,176 8,255 8,394 8,601 8,608 8,571 8,750 8,816 8,934 9,123 9,070
Total Noncurrent Assets
5,496 5,414 4,814 4,830 4,802 4,779 4,615 4,630 4,629 4,591 4,538
Goodwill
3,697 3,709 3,060 3,070 3,048 3,030 2,805 2,845 2,888 2,833 2,795
Intangible Assets
488 472 460 430 415 400 371 362 343 315 302
Other Noncurrent Operating Assets
1,311 1,233 1,294 1,330 1,339 1,349 1,439 1,423 1,398 1,443 1,441
Total Liabilities & Shareholders' Equity
17,128 16,429 15,243 15,716 15,624 15,066 15,412 15,746 15,362 15,815 16,119
Total Liabilities
11,940 11,215 10,870 11,284 10,793 10,376 10,824 10,725 10,478 10,805 10,691
Total Current Liabilities
3,380 2,273 2,083 2,341 1,823 1,886 2,039 1,864 2,552 2,681 2,507
Short-Term Debt
1,393 515 537 611 387 633 668 431 1,271 1,248 1,056
Accounts Payable
1,014 757 541 741 579 462 599 605 484 631 578
Other Current Liabilities
973 1,001 1,005 989 857 791 772 828 797 802 845
Other Current Nonoperating Liabilities
- - - - - - - 0.00 - - 28
Total Noncurrent Liabilities
8,560 8,942 8,787 8,943 8,970 8,490 8,785 8,861 7,926 8,124 8,184
Long-Term Debt
6,323 6,702 6,579 6,769 6,730 6,288 6,596 6,600 5,683 5,966 5,985
Noncurrent Deferred & Payable Income Tax Liabilities
958 958 905 913 1,030 1,019 1,021 1,081 1,015 1,005 1,100
Other Noncurrent Operating Liabilities
1,279 1,282 1,303 1,261 1,210 1,183 1,168 1,180 1,228 1,153 1,099
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
5,188 5,214 4,373 4,432 4,831 4,690 4,588 5,021 4,884 5,010 5,428
Total Preferred & Common Equity
5,180 5,205 4,364 4,423 4,822 4,681 4,580 5,012 4,874 5,001 5,419
Total Common Equity
5,013 5,038 4,197 4,256 4,655 4,681 4,580 5,012 4,874 5,001 5,419
Common Stock
1,482 1,492 1,500 1,501 1,505 1,675 1,679 1,684 1,703 1,724 1,731
Retained Earnings
3,808 3,842 2,974 3,042 3,460 3,331 3,272 3,671 3,428 3,550 3,990
Treasury Stock
-46 -55 -55 -55 -56 -56 -58 -75 -76 -105 -117
Accumulated Other Comprehensive Income / (Loss)
-231 -241 -222 -232 -254 -269 -313 -268 -181 -168 -185
Noncontrolling Interest
8.00 9.00 9.00 9.00 9.00 9.00 8.00 9.00 10 9.00 9.00

Annual Metrics And Ratios for UGI

This table displays calculated financial ratios and metrics derived from UGI's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 9/30/2015 9/30/2016 9/30/2017 9/30/2018 9/30/2019 9/30/2020 9/30/2021 9/30/2022 9/30/2023 9/30/2024 9/30/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-19.16% -15.03% 7.65% 25.00% -4.33% -10.40% 13.54% 35.71% -11.66% -19.24% 1.07%
EBITDA Growth
-11.66% 14.88% 0.55% 9.98% -28.13% 30.98% 98.06% -21.12% -140.68% 242.87% 34.40%
EBIT Growth
-16.97% 18.34% -0.78% 10.27% -39.32% 46.65% 145.53% -26.29% -183.34% 152.52% 61.32%
NOPAT Growth
-16.27% 16.46% 10.89% 35.75% -53.72% 65.27% 121.29% -25.57% -178.35% 160.27% 77.01%
Net Income Growth
-22.27% 18.07% 7.16% 56.93% -62.53% 72.73% 175.75% -26.79% -239.85% 117.91% 152.04%
EPS Growth
-16.67% 30.00% 18.27% 65.04% -65.27% 80.14% 172.44% -28.18% -244.06% 117.46% 147.20%
Operating Cash Flow Growth
15.75% -16.68% -0.55% 12.51% -0.65% 2.23% 34.39% -51.65% 54.61% 6.78% 3.81%
Free Cash Flow Firm Growth
-24.46% -4.96% -56.78% 158.98% -326.75% 146.34% -38.29% 13.35% -79.07% 562.09% 30.00%
Invested Capital Growth
0.47% 2.22% 7.35% 5.67% 22.14% 1.68% 13.37% 7.49% -8.93% 0.11% 2.69%
Revenue Q/Q Growth
-3.30% -1.84% 2.30% 2.12% -1.65% -0.39% 4.40% 5.16% -5.60% -2.20% -0.61%
EBITDA Q/Q Growth
1.19% -5.65% 9.55% 2.71% -10.88% 10.27% 35.48% -16.83% -9.27% -27.94% 14.88%
EBIT Q/Q Growth
0.34% -7.66% 12.43% 4.00% -17.49% 15.72% 46.07% -20.94% -5.99% -40.14% 23.39%
NOPAT Q/Q Growth
1.45% -7.42% 15.57% -2.16% -20.10% 31.12% 38.95% -18.41% -4.79% -38.52% 30.51%
Net Income Q/Q Growth
1.85% -11.45% 23.31% 1.04% -28.46% 35.61% 54.26% -20.80% -8.06% -60.03% 62.20%
EPS Q/Q Growth
2.56% -9.57% 10.31% 2.27% -23.78% 17.59% 52.42% -20.73% -7.67% -60.19% 61.78%
Operating Cash Flow Q/Q Growth
4.34% -8.41% 1.23% 3.81% -0.44% -1.29% 24.87% -44.15% 52.69% -7.73% -4.74%
Free Cash Flow Firm Q/Q Growth
-7.45% -19.69% -18.34% 25.57% -410.43% 155.02% -61.57% -20.93% 111.07% -20.36% 6.75%
Invested Capital Q/Q Growth
-0.45% 0.59% 2.59% 0.65% 20.48% 1.41% 12.08% 9.40% 0.97% -1.07% 0.72%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
44.16% 57.13% 53.64% 46.74% 40.94% 51.99% 64.90% 40.90% 22.30% 51.05% 49.86%
EBITDA Margin
18.07% 24.43% 22.82% 20.08% 15.08% 22.05% 38.46% 22.35% -10.29% 18.21% 22.46%
Operating Margin
12.48% 17.38% 16.50% 13.92% 8.43% 14.97% 31.56% 16.49% -16.17% 10.68% 15.19%
EBIT Margin
12.48% 17.38% 16.02% 14.13% 8.96% 14.67% 31.72% 17.23% -16.25% 10.57% 14.77%
Profit (Net Income) Margin
6.19% 8.60% 8.56% 10.74% 4.21% 8.11% 19.70% 10.63% -16.82% 3.73% 9.30%
Tax Burden Percent
69.96% 68.85% 74.68% 96.14% 76.81% 79.76% 73.76% 77.43% 81.76% 79.12% 97.41%
Interest Burden Percent
70.88% 71.86% 71.55% 79.09% 61.13% 69.33% 84.21% 79.67% 126.60% 44.62% 64.68%
Effective Tax Rate
30.04% 31.15% 25.32% 3.86% 23.19% 20.24% 26.24% 22.57% 0.00% 20.88% 2.59%
Return on Invested Capital (ROIC)
8.33% 9.58% 10.13% 12.92% 5.24% 7.81% 16.06% 10.84% -8.58% 5.42% 9.47%
ROIC Less NNEP Spread (ROIC-NNEP)
3.32% 4.14% 4.03% 7.88% 1.97% 3.65% 11.59% 7.30% -16.09% 0.46% 3.60%
Return on Net Nonoperating Assets (RNNOA)
3.11% 4.06% 4.15% 8.05% 2.53% 5.55% 14.29% 7.67% -20.12% 0.73% 5.37%
Return on Equity (ROE)
11.44% 13.64% 14.28% 20.97% 7.77% 13.36% 30.35% 18.51% -28.70% 6.15% 14.84%
Cash Return on Invested Capital (CROIC)
7.87% 7.38% 3.04% 7.40% -14.70% 6.14% 3.52% 3.62% 0.77% 5.32% 6.82%
Operating Return on Assets (OROA)
8.10% 9.25% 8.74% 9.18% 5.18% 7.04% 15.38% 10.15% -8.80% 5.00% 7.04%
Return on Assets (ROA)
4.02% 4.58% 4.67% 6.98% 2.43% 3.89% 9.55% 6.26% -9.11% 1.76% 4.44%
Return on Common Equity (ROCE)
8.46% 10.54% 11.69% 18.30% 7.35% 13.33% 29.62% 17.88% -27.75% 6.02% 14.81%
Return on Equity Simple (ROE_SIMPLE)
15.38% 17.19% 16.56% 22.33% 8.07% 12.89% 26.57% 17.71% -34.25% 6.19% 0.00%
Net Operating Profit after Tax (NOPAT)
584 680 754 1,024 474 783 1,733 1,290 -1,011 609 1,078
NOPAT Margin
8.73% 11.96% 12.32% 13.38% 6.47% 11.94% 23.27% 12.77% -11.32% 8.45% 14.80%
Net Nonoperating Expense Percent (NNEP)
5.02% 5.44% 6.10% 5.04% 3.26% 4.15% 4.47% 3.54% 7.51% 4.96% 5.87%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - - - 9.05%
Cost of Revenue to Revenue
55.84% 42.87% 46.36% 53.26% 59.06% 48.01% 35.10% 59.10% 77.70% 48.95% 50.14%
SG&A Expenses to Revenue
26.51% 33.10% 30.51% 26.31% 26.82% 29.14% 27.04% 20.07% 24.17% 29.57% 27.60%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
31.68% 39.75% 37.14% 32.82% 32.51% 37.02% 33.34% 24.41% 38.47% 40.37% 34.17%
Earnings before Interest and Taxes (EBIT)
835 988 980 1,081 656 962 2,362 1,741 -1,451 762 1,076
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1,209 1,389 1,397 1,536 1,104 1,446 2,864 2,259 -919 1,313 1,637
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.67 2.11 2.01 2.09 1.87 1.41 1.47 1.02 1.07 1.24 1.50
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 1,039.50 0.00 0.00 8.16 3.38 6.03 4.96 4.48
Price to Revenue (P/Rev)
0.67 1.05 1.04 1.01 0.98 0.89 1.05 0.60 0.51 0.75 0.98
Price to Earnings (P/E)
16.00 16.44 14.53 10.70 27.90 10.94 5.32 5.64 0.00 19.97 10.54
Dividend Yield
3.42% 2.69% 2.66% 2.31% 3.43% 4.69% 3.62% 4.88% 6.81% 6.00% 4.51%
Earnings Yield
6.25% 6.08% 6.88% 9.35% 3.58% 9.14% 18.81% 17.74% 0.00% 5.01% 9.48%
Enterprise Value to Invested Capital (EV/IC)
1.25 1.43 1.40 1.48 1.33 1.17 1.22 1.03 1.03 1.09 1.21
Enterprise Value to Revenue (EV/Rev)
1.31 1.81 1.77 1.58 1.81 1.80 1.87 1.26 1.29 1.70 1.91
Enterprise Value to EBITDA (EV/EBITDA)
7.25 7.41 7.75 7.88 11.97 8.17 4.87 5.64 0.00 9.34 8.50
Enterprise Value to EBIT (EV/EBIT)
10.51 10.41 11.05 11.19 20.14 12.28 5.91 7.32 0.00 16.10 12.93
Enterprise Value to NOPAT (EV/NOPAT)
15.02 15.12 14.36 11.81 27.88 15.08 8.06 9.88 0.00 20.14 12.90
Enterprise Value to Operating Cash Flow (EV/OCF)
7.54 10.61 11.23 11.15 12.26 10.72 9.43 17.81 10.41 10.38 11.34
Enterprise Value to Free Cash Flow (EV/FCFF)
15.91 19.63 47.82 20.62 0.00 19.17 36.72 29.58 127.82 20.54 17.92
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
1.08 1.14 1.21 1.12 1.72 1.54 1.23 1.15 1.65 1.64 1.49
Long-Term Debt to Equity
0.95 1.05 1.07 1.01 1.51 1.45 1.15 1.07 1.49 1.48 1.36
Financial Leverage
0.94 0.98 1.03 1.02 1.28 1.52 1.23 1.05 1.25 1.57 1.49
Leverage Ratio
2.85 2.98 3.06 3.01 3.20 3.43 3.18 2.96 3.15 3.49 3.34
Compound Leverage Factor
2.02 2.14 2.19 2.38 1.95 2.38 2.67 2.35 3.99 1.56 2.16
Debt to Total Capital
51.92% 53.20% 54.82% 52.82% 63.30% 60.67% 55.20% 53.54% 62.26% 62.13% 59.85%
Short-Term Debt to Total Capital
6.03% 4.18% 6.58% 5.11% 7.86% 3.80% 3.86% 3.95% 6.06% 6.09% 5.06%
Long-Term Debt to Total Capital
45.89% 49.02% 48.24% 47.71% 55.43% 56.86% 51.34% 49.59% 56.20% 56.04% 54.79%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.73% 1.24% 1.43% 0.00% 0.00%
Noncontrolling Interests to Total Capital
11.85% 9.77% 6.98% 4.82% 0.10% 0.09% 0.07% 0.06% 0.07% 0.08% 0.08%
Common Equity to Total Capital
36.23% 37.02% 38.20% 42.36% 36.61% 39.25% 43.00% 45.16% 36.24% 37.79% 40.08%
Debt to EBITDA
3.19 2.94 3.25 2.99 5.98 4.41 2.38 3.10 -7.89 5.44 4.36
Net Debt to EBITDA
2.81 2.55 2.80 2.59 5.49 4.14 2.07 2.89 -7.44 5.24 4.13
Long-Term Debt to EBITDA
2.82 2.71 2.86 2.70 5.24 4.14 2.21 2.87 -7.12 4.91 3.99
Debt to NOPAT
6.60 6.01 6.02 4.48 13.93 8.15 3.93 5.43 -7.17 11.73 6.62
Net Debt to NOPAT
5.81 5.20 5.18 3.89 12.79 7.63 3.43 5.06 -6.76 11.30 6.27
Long-Term Debt to NOPAT
5.84 5.54 5.30 4.05 12.20 7.64 3.66 5.03 -6.47 10.58 6.06
Altman Z-Score
1.48 1.56 1.55 1.84 1.40 1.32 1.74 1.70 0.77 1.19 1.39
Noncontrolling Interest Sharing Ratio
26.04% 22.76% 18.11% 12.71% 5.41% 0.24% 2.39% 3.38% 3.30% 2.10% 0.20%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.87 0.99 1.00 1.09 0.77 0.88 1.42 1.56 0.90 0.80 0.89
Quick Ratio
0.60 0.75 0.74 0.78 0.55 0.59 0.76 0.63 0.53 0.46 0.54
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
551 524 226 586 -1,330 616 380 431 90 597 776
Operating Cash Flow to CapEx
237.22% 171.99% 150.95% 189.02% 152.91% 168.24% 214.64% 89.05% 113.66% 148.49% 146.60%
Free Cash Flow to Firm to Interest Expense
2.28 1.89 0.80 2.55 -5.04 1.91 1.23 1.27 0.23 1.48 1.84
Operating Cash Flow to Interest Expense
4.81 3.49 3.41 4.72 4.08 3.42 4.78 2.11 2.85 2.93 2.91
Operating Cash Flow Less CapEx to Interest Expense
2.78 1.46 1.15 2.22 1.41 1.39 2.55 -0.26 0.34 0.96 0.93
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.65 0.53 0.55 0.65 0.58 0.48 0.49 0.59 0.54 0.47 0.48
Accounts Receivable Turnover
10.26 9.71 10.39 11.10 10.51 10.15 9.72 10.07 8.91 9.09 10.24
Inventory Turnover
11.27 10.83 11.61 13.66 15.77 13.37 7.36 10.53 12.64 8.36 9.18
Fixed Asset Turnover
1.40 1.11 1.14 1.35 1.17 0.96 1.03 1.30 1.08 0.83 0.82
Accounts Payable Turnover
8.76 6.22 6.83 8.14 8.64 6.89 3.98 6.91 9.22 6.10 6.93
Days Sales Outstanding (DSO)
35.58 37.60 35.14 32.89 34.73 35.98 37.54 36.24 40.98 40.17 35.64
Days Inventory Outstanding (DIO)
32.38 33.71 31.45 26.73 23.14 27.30 49.57 34.65 28.89 43.65 39.76
Days Payable Outstanding (DPO)
41.65 58.71 53.44 44.85 42.25 52.97 91.60 52.80 39.57 59.83 52.69
Cash Conversion Cycle (CCC)
26.31 12.60 13.14 14.77 15.62 10.30 -4.49 18.09 30.30 23.98 22.70
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
7,025 7,181 7,709 8,146 9,950 10,117 11,470 12,329 11,228 11,240 11,542
Invested Capital Turnover
0.95 0.80 0.82 0.97 0.81 0.65 0.69 0.85 0.76 0.64 0.64
Increase / (Decrease) in Invested Capital
33 156 528 437 1,804 167 1,353 859 -1,101 12 302
Enterprise Value (EV)
8,771 10,285 10,829 12,096 13,213 11,810 13,962 12,750 11,529 12,267 13,913
Market Capitalization
4,495 5,996 6,344 7,692 7,143 5,821 7,801 6,049 4,520 5,372 7,148
Book Value per Share
$15.58 $16.42 $18.25 $21.17 $21.89 $19.82 $25.39 $28.20 $20.14 $20.24 $22.23
Tangible Book Value per Share
($5.04) ($4.19) ($3.20) $0.04 ($2.00) ($0.32) $4.57 $8.56 $3.58 $5.04 $7.43
Total Capital
7,430 7,682 8,280 8,690 10,427 10,518 12,347 13,074 11,643 11,497 11,920
Total Debt
3,857 4,087 4,539 4,590 6,600 6,381 6,816 7,000 7,249 7,143 7,134
Total Long-Term Debt
3,410 3,766 3,995 4,147 5,780 5,981 6,339 6,483 6,543 6,443 6,531
Net Debt
3,395 3,538 3,907 3,986 6,060 5,980 5,939 6,531 6,834 6,886 6,756
Capital Expenditures (CapEx)
491 564 639 574 705 655 690 804 974 796 837
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-234 -246 -80 -5.00 -182 -213 573 1,406 62 34 10
Debt-free Net Working Capital (DFNWC)
229 303 552 600 358 188 1,450 1,875 477 291 388
Net Working Capital (NWC)
-219 -18 7.40 156 -462 -212 973 1,358 -229 -409 -215
Net Nonoperating Expense (NNE)
170 191 230 202 166 251 266 216 491 340 400
Net Nonoperating Obligations (NNO)
3,452 3,586 3,968 4,046 6,123 5,980 5,939 6,255 6,834 6,886 6,756
Total Depreciation and Amortization (D&A)
374 401 416 455 448 484 502 518 532 551 561
Debt-free, Cash-free Net Working Capital to Revenue
-3.49% -4.33% -1.31% -0.07% -2.49% -3.25% 7.69% 13.91% 0.69% 0.47% 0.14%
Debt-free Net Working Capital to Revenue
3.42% 5.33% 9.02% 7.84% 4.89% 2.87% 19.47% 18.55% 5.34% 4.04% 5.32%
Net Working Capital to Revenue
-3.27% -0.32% 0.12% 2.04% -6.31% -3.23% 13.07% 13.44% -2.57% -5.67% -2.95%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$1.62 $2.11 $2.51 $4.13 $1.44 $2.55 $7.02 $5.11 ($7.16) $1.27 $3.15
Adjusted Weighted Average Basic Shares Outstanding
173.12M 173.15M 173.66M 173.91M 178.42M 208.93M 209.06M 209.94M 209.81M 211.31M 214.95M
Adjusted Diluted Earnings per Share
$1.60 $2.08 $2.46 $4.06 $1.41 $2.54 $6.92 $4.97 ($7.16) $1.25 $3.09
Adjusted Weighted Average Diluted Shares Outstanding
175.67M 175.57M 177.16M 176.91M 181.11M 209.87M 212.13M 215.82M 209.81M 215.27M 219.16M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
172.44M 172.98M 173.15M 173.85M 209.01M 208.42M 209.22M 209.69M 210.90M 214.70M 214.53M
Normalized Net Operating Profit after Tax (NOPAT)
584 680 754 1,096 474 826 1,733 1,290 -552 763 1,078
Normalized NOPAT Margin
8.73% 11.96% 12.32% 14.32% 6.47% 12.60% 23.27% 12.77% -6.18% 10.59% 14.80%
Pre Tax Income Margin
8.84% 12.49% 11.46% 11.18% 5.48% 10.17% 26.71% 13.72% -20.58% 4.72% 9.55%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
3.45 3.56 3.46 4.70 2.48 2.99 7.62 5.12 -3.74 1.89 2.56
NOPAT to Interest Expense
2.41 2.45 2.66 4.45 1.80 2.43 5.59 3.79 -2.61 1.51 2.56
EBIT Less CapEx to Interest Expense
1.42 1.53 1.21 2.20 -0.19 0.95 5.39 2.76 -6.25 -0.08 0.57
NOPAT Less CapEx to Interest Expense
0.39 0.42 0.41 1.96 -0.88 0.40 3.37 1.43 -5.12 -0.46 0.57
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
97.20% 85.52% 82.19% 53.53% 322.08% 51.32% 19.22% 27.56% -20.51% 118.22% 47.49%
Augmented Payout Ratio
105.43% 95.25% 90.45% 60.83% 327.60% 58.46% 19.22% 31.10% -21.97% 118.22% 52.36%

Quarterly Metrics And Ratios for UGI

This table displays calculated financial ratios and metrics derived from UGI's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
- - - - - - - - - - 214,636,337.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 214,636,337.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 2.42
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-27.40% -23.12% -20.57% -16.82% -11.54% -4.29% 8.07% 1.01% -3.62% 2.61% 0.71%
EBITDA Growth
-16.67% 129.25% 121.34% 135.18% -130.51% 103.11% -3.48% -120.95% 247.58% -8.56% 8.78%
EBIT Growth
-24.33% 115.50% 183.27% 109.71% -200.39% 170.16% -4.81% -2,000.00% 114.56% -11.24% 10.53%
NOPAT Growth
-27.22% 121.56% 230.57% 109.15% -187.08% 140.98% -0.16% -238.81% 105.28% -12.28% 5.80%
Net Income Growth
-46.09% 109.85% 350.91% 93.92% -308.40% 298.94% -3.43% -239.58% 95.24% -20.80% 8.56%
EPS Growth
-44.74% 109.69% 350.98% 93.88% -300.00% 295.45% -4.78% -230.43% 93.65% -22.99% 6.39%
Operating Cash Flow Growth
289.39% 149.58% -21.39% -9.93% -39.60% 37.82% 31.03% -25.90% -40.40% -59.76% -2.92%
Free Cash Flow Firm Growth
321.14% 158.63% 500.70% 46.44% -114.18% -57.72% -31.99% 15.46% -59.01% -100.24% -44.84%
Invested Capital Growth
-8.93% -5.39% -2.65% 2.17% 0.11% 0.74% -0.30% 0.87% 2.69% 3.33% 2.30%
Revenue Q/Q Growth
-15.37% 51.07% 16.31% -44.06% -10.00% 63.45% 31.33% -47.71% -14.13% 74.02% 28.90%
EBITDA Q/Q Growth
165.33% -17.44% 146.00% -75.61% -156.67% 649.58% 27.06% -103.73% 690.32% 226.78% 51.17%
EBIT Q/Q Growth
134.88% -25.10% 232.42% -90.25% -460.56% 301.56% 34.30% -124.68% 122.22% 1,105.26% 67.25%
NOPAT Q/Q Growth
138.59% -8.10% 211.11% -91.70% -467.16% 354.33% 28.89% -111.53% 113.98% 4,121.47% 55.46%
Net Income Q/Q Growth
116.60% -28.24% 427.66% -109.68% -468.75% 237.36% 27.73% -134.03% 92.02% 2,384.62% 75.08%
EPS Q/Q Growth
116.76% -30.16% 422.73% -110.00% -447.83% 238.10% 25.86% -134.70% 89.47% 1,775.00% 73.88%
Operating Cash Flow Q/Q Growth
-42.26% -52.40% 338.66% -25.29% -61.28% 8.61% 317.07% -57.75% -68.86% -26.67% 906.06%
Free Cash Flow Firm Q/Q Growth
458.38% -35.73% 5.59% -122.02% 5.10% 291.61% 69.85% -127.37% -78.49% 99.71% 39,243.25%
Invested Capital Q/Q Growth
0.97% 2.15% 1.16% -2.08% -1.07% 2.79% 0.11% -0.93% 0.72% 3.44% -0.90%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
58.76% 43.33% 58.25% 53.70% 47.02% 54.53% 51.20% 39.96% 50.46% 51.42% 55.79%
EBITDA Margin
27.78% 15.18% 34.90% 15.22% -9.58% 32.22% 31.17% -2.22% 15.29% 28.71% 33.67%
Operating Margin
16.88% 10.94% 29.06% 4.86% -19.81% 23.99% 26.26% -6.67% 1.09% 21.80% 28.23%
EBIT Margin
18.16% 9.01% 29.51% 5.14% -20.61% 25.42% 25.99% -12.27% 3.17% 21.99% 28.53%
Profit (Net Income) Margin
9.33% 4.43% 20.11% -3.48% -21.98% 18.47% 17.97% -11.69% -1.09% 14.26% 19.37%
Tax Burden Percent
83.44% 78.33% 78.86% 87.27% 77.12% 89.93% 80.64% 71.49% 14.94% 84.62% 78.79%
Interest Burden Percent
61.57% 62.83% 86.40% -77.46% 138.28% 80.81% 85.71% 133.33% -228.95% 76.64% 86.16%
Effective Tax Rate
16.56% 21.67% 21.14% 0.00% 0.00% 10.07% 19.36% 0.00% 0.00% 15.38% 21.21%
Return on Invested Capital (ROIC)
10.68% 6.02% 14.91% 2.23% -8.90% 13.34% 13.38% -3.00% 0.49% 11.52% 13.99%
ROIC Less NNEP Spread (ROIC-NNEP)
9.66% 4.77% 13.88% 0.81% -10.37% 12.44% 12.09% -4.48% 0.16% 10.27% 12.80%
Return on Net Nonoperating Assets (RNNOA)
12.07% 6.92% 18.62% 1.21% -16.26% 19.32% 16.34% -6.20% 0.24% 14.87% 15.86%
Return on Equity (ROE)
22.75% 12.94% 33.53% 3.43% -25.16% 32.66% 29.72% -9.20% 0.73% 26.39% 29.85%
Cash Return on Invested Capital (CROIC)
0.77% 5.49% -1.01% 6.67% 5.32% 6.95% 8.01% 6.37% 6.82% 5.43% 6.64%
Operating Return on Assets (OROA)
9.83% 4.55% 14.09% 2.50% -9.75% 11.63% 12.13% -5.91% 1.51% 10.34% 13.18%
Return on Assets (ROA)
5.05% 2.24% 9.60% -1.69% -10.39% 8.45% 8.38% -5.64% -0.52% 6.70% 8.95%
Return on Common Equity (ROCE)
22.00% 12.47% 32.36% 3.36% -24.63% 31.99% 29.16% -9.18% 0.73% 26.34% 29.80%
Return on Equity Simple (ROE_SIMPLE)
0.00% -10.26% -1.41% 14.38% 0.00% 12.01% 10.63% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
198 182 565 47 -172 438 564 -65 9.10 384 597
NOPAT Margin
14.08% 8.57% 22.92% 3.40% -13.86% 21.57% 21.17% -4.67% 0.76% 18.44% 22.24%
Net Nonoperating Expense Percent (NNEP)
1.02% 1.26% 1.03% 1.41% 1.47% 0.90% 1.28% 1.48% 0.32% 1.25% 1.19%
Return On Investment Capital (ROIC_SIMPLE)
- 1.54% - - - 3.70% 4.68% -0.55% 0.08% 3.14% 4.79%
Cost of Revenue to Revenue
41.24% 56.67% 41.75% 46.30% 52.98% 45.47% 48.80% 60.04% 49.54% 48.58% 44.21%
SG&A Expenses to Revenue
36.97% 24.99% 23.96% 36.30% 41.06% 24.48% 20.48% 34.51% 40.69% 24.96% 20.82%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
41.88% 31.07% 29.19% 48.77% 66.91% 30.54% 24.94% 42.75% 50.88% 29.62% 27.56%
Earnings before Interest and Taxes (EBIT)
255 191 728 71 -256 516 693 -171 38 458 766
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
390 322 861 210 -119 654 831 -31 183 598 904
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.07 1.14 1.09 1.03 1.24 1.32 1.42 1.60 1.50 1.61 1.44
Price to Tangible Book Value (P/TBV)
6.03 6.42 4.24 3.84 4.96 4.32 3.94 4.75 4.48 4.33 3.37
Price to Revenue (P/Rev)
0.51 0.59 0.66 0.65 0.75 0.85 0.97 1.07 0.98 1.09 1.06
Price to Earnings (P/E)
0.00 0.00 0.00 7.13 19.97 11.02 13.33 18.68 10.54 13.38 12.20
Dividend Yield
6.81% 6.41% 6.22% 6.55% 6.00% 5.31% 4.54% 4.12% 4.51% 4.01% 4.12%
Earnings Yield
0.00% 0.00% 0.00% 14.02% 5.01% 9.07% 7.50% 5.35% 9.48% 7.47% 8.20%
Enterprise Value to Invested Capital (EV/IC)
1.03 1.05 1.03 1.01 1.09 1.13 1.18 1.26 1.21 1.25 1.21
Enterprise Value to Revenue (EV/Rev)
1.29 1.46 1.57 1.56 1.70 1.83 1.87 1.96 1.91 2.04 1.94
Enterprise Value to EBITDA (EV/EBITDA)
0.00 23.65 11.83 6.30 9.34 7.95 8.52 10.10 8.50 9.47 8.63
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 25.49 9.02 16.10 11.99 12.98 16.51 12.93 14.70 13.09
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 11.59 20.14 14.73 15.30 17.42 12.90 14.63 13.70
Enterprise Value to Operating Cash Flow (EV/OCF)
10.41 8.23 9.07 8.96 10.38 10.62 9.83 11.18 11.34 13.26 12.88
Enterprise Value to Free Cash Flow (EV/FCFF)
127.82 18.63 0.00 15.31 20.54 16.29 14.73 19.79 17.92 23.47 18.39
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
1.65 1.67 1.47 1.48 1.64 1.58 1.40 1.42 1.49 1.44 1.30
Long-Term Debt to Equity
1.49 1.53 1.39 1.34 1.48 1.44 1.31 1.16 1.36 1.19 1.10
Financial Leverage
1.25 1.45 1.34 1.48 1.57 1.55 1.35 1.38 1.49 1.45 1.24
Leverage Ratio
3.15 3.41 3.19 3.34 3.49 3.45 3.18 3.18 3.34 3.25 3.05
Compound Leverage Factor
1.94 2.15 2.76 -2.59 4.82 2.79 2.73 4.24 -7.66 2.49 2.63
Debt to Total Capital
62.26% 62.48% 59.57% 59.61% 62.13% 61.29% 58.34% 58.74% 59.85% 59.02% 56.47%
Short-Term Debt to Total Capital
6.06% 5.17% 3.24% 5.45% 6.09% 5.64% 3.58% 10.74% 5.06% 10.21% 8.47%
Long-Term Debt to Total Capital
56.20% 57.31% 56.33% 54.16% 56.04% 55.65% 54.76% 48.01% 54.79% 48.81% 48.00%
Preferred Equity to Total Capital
1.43% 1.41% 1.40% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.07% 0.08% 0.08% 0.08% 0.08% 0.07% 0.07% 0.08% 0.08% 0.07% 0.07%
Common Equity to Total Capital
36.24% 36.03% 38.96% 40.32% 37.79% 38.64% 41.59% 41.17% 40.08% 40.91% 43.46%
Debt to EBITDA
-7.89 14.47 7.01 3.80 5.44 4.43 4.38 4.88 4.36 4.56 4.26
Net Debt to EBITDA
-7.44 13.80 6.67 3.66 5.24 4.25 4.08 4.61 4.13 4.38 3.90
Long-Term Debt to EBITDA
-7.12 13.27 6.63 3.45 4.91 4.02 4.11 3.99 3.99 3.77 3.62
Debt to NOPAT
-7.17 -1,317.86 -16.37 6.98 11.73 8.21 7.88 8.42 6.62 7.05 6.75
Net Debt to NOPAT
-6.76 -1,256.61 -15.57 6.73 11.30 7.87 7.33 7.96 6.27 6.77 6.19
Long-Term Debt to NOPAT
-6.47 -1,208.75 -15.48 6.35 10.58 7.45 7.40 6.88 6.06 5.83 5.74
Altman Z-Score
1.14 1.09 1.26 1.08 0.97 1.21 1.37 1.14 1.17 1.28 1.40
Noncontrolling Interest Sharing Ratio
3.30% 3.65% 3.50% 2.04% 2.10% 2.04% 1.88% 0.20% 0.20% 0.18% 0.17%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.90 0.98 1.21 0.91 0.80 1.00 1.23 0.70 0.89 0.78 1.00
Quick Ratio
0.53 0.61 0.82 0.56 0.46 0.64 0.89 0.46 0.54 0.49 0.69
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
1,299 835 881 -194 -184 353 599 -164 -293 -0.85 331
Operating Cash Flow to CapEx
82.24% 81.51% 308.88% 190.24% 56.77% 79.23% 499.27% 130.18% 34.88% 29.86% 390.59%
Free Cash Flow to Firm to Interest Expense
13.25 8.35 8.81 -1.88 -1.84 3.46 5.88 -1.48 -2.76 -0.01 2.98
Operating Cash Flow to Interest Expense
2.55 1.19 5.22 3.79 1.51 1.61 6.71 2.60 0.85 0.59 5.98
Operating Cash Flow Less CapEx to Interest Expense
-0.55 -0.27 3.53 1.80 -1.15 -0.42 5.36 0.60 -1.58 -1.40 4.45
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.54 0.50 0.48 0.49 0.47 0.46 0.47 0.48 0.48 0.47 0.46
Accounts Receivable Turnover
8.91 5.99 5.71 8.27 9.09 6.44 6.16 8.88 10.24 7.07 6.23
Inventory Turnover
12.64 9.51 9.69 8.75 8.36 7.91 9.84 10.08 9.18 9.68 11.00
Fixed Asset Turnover
1.08 0.99 0.91 0.87 0.83 0.82 0.84 0.84 0.82 0.82 0.82
Accounts Payable Turnover
9.22 5.74 5.86 6.88 6.10 4.85 5.95 7.86 6.93 6.09 6.14
Days Sales Outstanding (DSO)
40.98 60.89 63.90 44.11 40.17 56.68 59.23 41.12 35.64 51.59 58.55
Days Inventory Outstanding (DIO)
28.89 38.40 37.67 41.74 43.65 46.16 37.11 36.22 39.76 37.69 33.19
Days Payable Outstanding (DPO)
39.57 63.64 62.28 53.06 59.83 75.25 61.37 46.42 52.69 59.97 59.49
Cash Conversion Cycle (CCC)
30.30 35.65 39.29 32.79 23.98 27.59 34.97 30.91 22.70 29.31 32.25
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
11,228 11,469 11,602 11,361 11,240 11,554 11,567 11,460 11,542 11,939 11,832
Invested Capital Turnover
0.76 0.70 0.65 0.66 0.64 0.62 0.63 0.64 0.64 0.62 0.63
Increase / (Decrease) in Invested Capital
-1,101 -653 -316 241 12 85 -35 99 302 385 266
Enterprise Value (EV)
11,529 12,063 12,004 11,480 12,267 13,035 13,659 14,396 13,913 14,968 14,279
Market Capitalization
4,520 4,850 5,057 4,800 5,372 6,061 7,104 7,810 7,148 8,030 7,817
Book Value per Share
$20.14 $20.29 $22.21 $22.33 $20.24 $21.33 $23.33 $22.73 $22.23 $23.31 $25.25
Tangible Book Value per Share
$3.58 $3.60 $5.69 $5.97 $5.04 $6.54 $8.40 $7.66 $7.43 $8.64 $10.82
Total Capital
11,643 11,812 11,948 11,611 11,497 11,852 12,052 11,838 11,920 12,224 12,469
Total Debt
7,249 7,380 7,117 6,921 7,143 7,264 7,031 6,954 7,134 7,214 7,041
Total Long-Term Debt
6,543 6,769 6,730 6,288 6,443 6,596 6,600 5,683 6,531 5,966 5,985
Net Debt
6,834 7,037 6,771 6,671 6,886 6,966 6,546 6,576 6,756 6,929 6,453
Capital Expenditures (CapEx)
304 146 169 205 266 207 137 222 258 221 170
Debt-free, Cash-free Net Working Capital (DFCFNWC)
62 212 432 213 34 378 382 140 10 383 472
Debt-free Net Working Capital (DFNWC)
477 555 778 463 291 676 867 518 388 668 1,060
Net Working Capital (NWC)
-229 -56 391 -170 -409 8.00 436 -753 -215 -580 4.00
Net Nonoperating Expense (NNE)
67 88 69 95 101 63 85 98 22 87 77
Net Nonoperating Obligations (NNO)
6,834 7,037 6,771 6,671 6,886 6,966 6,546 6,576 6,756 6,929 6,404
Total Depreciation and Amortization (D&A)
135 131 133 139 137 138 138 140 145 140 138
Debt-free, Cash-free Net Working Capital to Revenue
0.69% 2.56% 5.65% 2.89% 0.47% 5.31% 5.22% 1.91% 0.14% 5.22% 6.41%
Debt-free Net Working Capital to Revenue
5.34% 6.69% 10.17% 6.28% 4.04% 9.50% 11.85% 7.06% 5.32% 9.10% 14.40%
Net Working Capital to Revenue
-2.57% -0.68% 5.11% -2.31% -5.67% 0.11% 5.96% -10.27% -2.95% -7.90% 0.05%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.62 $0.45 $2.36 ($0.23) ($1.31) $1.74 $2.23 ($0.76) ($0.06) $1.38 $2.42
Adjusted Weighted Average Basic Shares Outstanding
209.81M 209.78M 209.83M 210.68M 211.31M 214.93M 214.98M 214.81M 214.95M 214.84M 214.83M
Adjusted Diluted Earnings per Share
$0.63 $0.44 $2.30 ($0.23) ($1.26) $1.74 $2.19 ($0.76) ($0.08) $1.34 $2.33
Adjusted Weighted Average Diluted Shares Outstanding
209.81M 215.57M 215.25M 210.68M 215.27M 215.70M 218.94M 214.81M 219.16M 221.42M 222.71M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
210.90M 209.55M 209.62M 214.69M 214.70M 214.81M 214.44M 214.92M 214.53M 214.64M 214.39M
Normalized Net Operating Profit after Tax (NOPAT)
198 182 565 90 -172 438 564 -65 9.10 384 597
Normalized NOPAT Margin
14.08% 8.57% 22.92% 6.54% -13.86% 21.57% 21.17% -4.67% 0.76% 18.44% 22.24%
Pre Tax Income Margin
11.18% 5.66% 25.50% -3.99% -28.50% 20.54% 22.28% -16.36% -7.27% 16.85% 24.58%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
2.60 1.91 7.28 0.69 -2.56 5.06 6.79 -1.54 0.36 4.13 6.90
NOPAT to Interest Expense
2.02 1.82 5.65 0.46 -1.72 4.29 5.53 -0.59 0.09 3.46 5.38
EBIT Less CapEx to Interest Expense
-0.50 0.45 5.59 -1.30 -5.22 3.03 5.45 -3.54 -2.08 2.14 5.37
NOPAT Less CapEx to Interest Expense
-1.08 0.36 3.96 -1.54 -4.38 2.26 4.19 -2.59 -2.35 1.47 3.85
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
-20.51% -68.50% -461.76% 46.95% 118.22% 58.18% 60.41% 76.79% 47.49% 53.67% 50.23%
Augmented Payout Ratio
-21.97% -70.70% -461.76% 46.95% 118.22% 57.45% 62.10% 77.99% 52.36% 61.17% 56.32%

Financials Breakdown Chart

Key Financial Trends

Below is a concise, bullet-point style overview of trends in UGI's quarterly statements over the last four years, focusing on factors that may matter to retail investors.

  • In Q2 2025, UGI reported substantial earnings with net income of $479 million and robust operating cash flow of $684 million from continuing operations, signaling strong profitability and cash generation in that quarter.
  • In the most recent quarter, Q1 2026, Consolidated net income reached $297 million, with net cash from continuing operating activities of $66 million, indicating ongoing profitability and cash generation into 2026.
  • UGI continues to return cash to shareholders, with cash dividends per share of $0.375 in Q1 2026, reflecting a stable and ongoing dividend policy.
  • The company has accessed debt markets to support liquidity and growth, including a $546 million debt issuance in Q3 2025 and a $350 million issuance in Q4 2025, providing flexibility for capex and working capital needs.
  • Cash and equivalents were solid around $251 million at the end of Q1 2026, helping to support near-term liquidity needs.
  • A one-off impairment charge of $656 million in Q3 2025 reduced pretax income, illustrating that earnings in that period were affected by a non-recurring write-down rather than ongoing operating performance.
  • UGI's leverage remains relatively high, with long-term debt typically in the $6–7 billion range across recent years, contributing to meaningful interest expense and a higher debt service burden.
  • Quarterly net income has shown volatility, including a notable loss in Q3 2025 (net income from continuing operations around -$163 million) and a smaller quarterly loss in Q4 2025, signaling earnings swings.
  • Net cash from financing activities has often been negative in recent quarters, driven by debt repayments and shareholder returns; for example, Q3 2025 financing cash flow was around -$237 million and Q1 2026 was about -$6 million.
  • Free cash flow can be negative in some periods due to outsized capital expenditures; for instance, quarterly capex (Purchase of PPE) has run around $221–$258 million while operating cash flow has been more modest in certain quarters, reducing near-term free cash flow.
05/14/26 07:35 AM ETAI Generated. May Contain Errors.

UGI Financials - Frequently Asked Questions

According to the most recent income statement we have on file, UGI's fiscal year ends in September. Their fiscal year 2025 ended on September 30, 2025.

UGI's net income appears to be on a downward trend, with a most recent value of $678 million in 2025, rising from $414 million in 2015. The previous period was $269 million in 2024. Check out UGI's forecast to explore projected trends and price targets.

UGI's total operating income in 2025 was $1.11 billion, based on the following breakdown:
  • Total Gross Profit: $3.63 billion
  • Total Operating Expenses: $2.49 billion

Over the last 10 years, UGI's total revenue changed from $6.69 billion in 2015 to $7.29 billion in 2025, a change of 8.9%.

UGI's total liabilities were at $10.68 billion at the end of 2025, a 0.6% decrease from 2024, and a 53.8% increase since 2015.

In the past 10 years, UGI's cash and equivalents has ranged from $213 million in 2024 to $855 million in 2021, and is currently $335 million as of their latest financial filing in 2025.

Over the last 10 years, UGI's book value per share changed from 15.58 in 2015 to 22.23 in 2025, a change of 42.7%.



Financial statements for NYSE:UGI last updated on 5/8/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners